The findings reported in this study provide new insights into the regulatory function of the fibrotic liver microenvironment in stem cell therapy and demonstrate the dual role of FSTL1 as a fibrotic microenvironmental modulator and outcome-predicting functional surrogate of stem cell therapy in liver fibrosis. The gene discussed is FSTL1; the disease is Hepatic fibrosis.